Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.

Cite this paper

@article{Conway2008EffectsOT, title={Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.}, author={James G. Conway and Heather M Pink and Mandy L Bergquist and Bajin Han and Scott Depee and Sarva M Tadepalli and Peiyuan Lin and R. Christian Crumrine and Jane G Binz and Richard L. Clark and Jeffrey L Selph and Stephen A. Stimpson and Jeff T. Hutchins and Stanley D Chamberlain and Thomas A Brodie}, journal={The Journal of pharmacology and experimental therapeutics}, year={2008}, volume={326 1}, pages={41-50} }